α-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus

Srinath Setty, Wei Sun, Rodolfo Martinez, H. Fred Downey, Johnathan Tune

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

This study tested whether α-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in diabetes mellitus. Experiments were conducted in dogs instrumented with catheters in the aorta and coronary sinus and with a flow transducer around the circumflex coronary artery. Diabetes was induced with alloxan monohydrate (n = 8, 40 mg/kg iv). Arterial plasma glucose concentration increased from 4.7 ± 0.2 mM in nondiabetic, control dogs (n = 8) to 21.4 ± 1.9 mM 1 wk after alloxan injection. Coronary blood flow, myocardial oxygen consumption (MV̇O2), aortic pressure, and heart rate were measured at rest and during graded treadmill exercise before and after infusion of the α-adrenoceptor antagonist phentolamine (1 mg/kg iv). In untreated diabetic dogs, exercise increased MV̇O2 2.7-fold, coronary blood flow 2.2-fold, and heart rate 2.3-fold. Coronary venous Po2 fell as MV̇O2 increased during exercise. After α-adrenoceptor blockade, exercise increased MV̇O2 3.1-fold, coronary blood flow 2.7-fold, and heart rate 2.1-fold. Relative to untreated diabetic dogs, α-adrenoceptor blockade significantly decreased the slope of the relationship between coronary venous PO2 and MV̇O2. The difference between the untreated and phentolamine-treated slopes was greater in the diabetic dogs than in the nondiabetic dogs. In addition, the decrease in coronary blood flow to intracoronary norepinephrine infusion was significantly augmented in anesthetized, open-chest, β-adrenoceptor-blocked diabetic dogs compared with the nondiabetic dogs. These findings demonstrate that α-adrenoceptor- mediated coronary vasoconstriction is augmented in alloxan-induced diabetic dogs during physiological increases in MV̇O2.

Original languageEnglish (US)
Pages (from-to)431-438
Number of pages8
JournalJournal of Applied Physiology
Volume97
Issue number1
DOIs
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

Experimental Diabetes Mellitus
Vasoconstriction
Adrenergic Receptors
Dogs
Alloxan
Phentolamine
Heart Rate
Coronary Sinus
Transducers
Oxygen Consumption
Aorta
Coronary Vessels
Norepinephrine
Diabetes Mellitus
Arterial Pressure
Thorax
Catheters
Glucose
Injections

Keywords

  • Coronary blood flow
  • Myocardial oxygen consumption

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

α-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus. / Setty, Srinath; Sun, Wei; Martinez, Rodolfo; Downey, H. Fred; Tune, Johnathan.

In: Journal of Applied Physiology, Vol. 97, No. 1, 07.2004, p. 431-438.

Research output: Contribution to journalArticle

Setty, Srinath ; Sun, Wei ; Martinez, Rodolfo ; Downey, H. Fred ; Tune, Johnathan. / α-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus. In: Journal of Applied Physiology. 2004 ; Vol. 97, No. 1. pp. 431-438.
@article{527976e7be41482f92c2172ea882e6f2,
title = "α-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus",
abstract = "This study tested whether α-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in diabetes mellitus. Experiments were conducted in dogs instrumented with catheters in the aorta and coronary sinus and with a flow transducer around the circumflex coronary artery. Diabetes was induced with alloxan monohydrate (n = 8, 40 mg/kg iv). Arterial plasma glucose concentration increased from 4.7 ± 0.2 mM in nondiabetic, control dogs (n = 8) to 21.4 ± 1.9 mM 1 wk after alloxan injection. Coronary blood flow, myocardial oxygen consumption (MV̇O2), aortic pressure, and heart rate were measured at rest and during graded treadmill exercise before and after infusion of the α-adrenoceptor antagonist phentolamine (1 mg/kg iv). In untreated diabetic dogs, exercise increased MV̇O2 2.7-fold, coronary blood flow 2.2-fold, and heart rate 2.3-fold. Coronary venous Po2 fell as MV̇O2 increased during exercise. After α-adrenoceptor blockade, exercise increased MV̇O2 3.1-fold, coronary blood flow 2.7-fold, and heart rate 2.1-fold. Relative to untreated diabetic dogs, α-adrenoceptor blockade significantly decreased the slope of the relationship between coronary venous PO2 and MV̇O2. The difference between the untreated and phentolamine-treated slopes was greater in the diabetic dogs than in the nondiabetic dogs. In addition, the decrease in coronary blood flow to intracoronary norepinephrine infusion was significantly augmented in anesthetized, open-chest, β-adrenoceptor-blocked diabetic dogs compared with the nondiabetic dogs. These findings demonstrate that α-adrenoceptor- mediated coronary vasoconstriction is augmented in alloxan-induced diabetic dogs during physiological increases in MV̇O2.",
keywords = "Coronary blood flow, Myocardial oxygen consumption",
author = "Srinath Setty and Wei Sun and Rodolfo Martinez and Downey, {H. Fred} and Johnathan Tune",
year = "2004",
month = "7",
doi = "10.1152/japplphysiol.01122.2003",
language = "English (US)",
volume = "97",
pages = "431--438",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - α-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus

AU - Setty, Srinath

AU - Sun, Wei

AU - Martinez, Rodolfo

AU - Downey, H. Fred

AU - Tune, Johnathan

PY - 2004/7

Y1 - 2004/7

N2 - This study tested whether α-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in diabetes mellitus. Experiments were conducted in dogs instrumented with catheters in the aorta and coronary sinus and with a flow transducer around the circumflex coronary artery. Diabetes was induced with alloxan monohydrate (n = 8, 40 mg/kg iv). Arterial plasma glucose concentration increased from 4.7 ± 0.2 mM in nondiabetic, control dogs (n = 8) to 21.4 ± 1.9 mM 1 wk after alloxan injection. Coronary blood flow, myocardial oxygen consumption (MV̇O2), aortic pressure, and heart rate were measured at rest and during graded treadmill exercise before and after infusion of the α-adrenoceptor antagonist phentolamine (1 mg/kg iv). In untreated diabetic dogs, exercise increased MV̇O2 2.7-fold, coronary blood flow 2.2-fold, and heart rate 2.3-fold. Coronary venous Po2 fell as MV̇O2 increased during exercise. After α-adrenoceptor blockade, exercise increased MV̇O2 3.1-fold, coronary blood flow 2.7-fold, and heart rate 2.1-fold. Relative to untreated diabetic dogs, α-adrenoceptor blockade significantly decreased the slope of the relationship between coronary venous PO2 and MV̇O2. The difference between the untreated and phentolamine-treated slopes was greater in the diabetic dogs than in the nondiabetic dogs. In addition, the decrease in coronary blood flow to intracoronary norepinephrine infusion was significantly augmented in anesthetized, open-chest, β-adrenoceptor-blocked diabetic dogs compared with the nondiabetic dogs. These findings demonstrate that α-adrenoceptor- mediated coronary vasoconstriction is augmented in alloxan-induced diabetic dogs during physiological increases in MV̇O2.

AB - This study tested whether α-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in diabetes mellitus. Experiments were conducted in dogs instrumented with catheters in the aorta and coronary sinus and with a flow transducer around the circumflex coronary artery. Diabetes was induced with alloxan monohydrate (n = 8, 40 mg/kg iv). Arterial plasma glucose concentration increased from 4.7 ± 0.2 mM in nondiabetic, control dogs (n = 8) to 21.4 ± 1.9 mM 1 wk after alloxan injection. Coronary blood flow, myocardial oxygen consumption (MV̇O2), aortic pressure, and heart rate were measured at rest and during graded treadmill exercise before and after infusion of the α-adrenoceptor antagonist phentolamine (1 mg/kg iv). In untreated diabetic dogs, exercise increased MV̇O2 2.7-fold, coronary blood flow 2.2-fold, and heart rate 2.3-fold. Coronary venous Po2 fell as MV̇O2 increased during exercise. After α-adrenoceptor blockade, exercise increased MV̇O2 3.1-fold, coronary blood flow 2.7-fold, and heart rate 2.1-fold. Relative to untreated diabetic dogs, α-adrenoceptor blockade significantly decreased the slope of the relationship between coronary venous PO2 and MV̇O2. The difference between the untreated and phentolamine-treated slopes was greater in the diabetic dogs than in the nondiabetic dogs. In addition, the decrease in coronary blood flow to intracoronary norepinephrine infusion was significantly augmented in anesthetized, open-chest, β-adrenoceptor-blocked diabetic dogs compared with the nondiabetic dogs. These findings demonstrate that α-adrenoceptor- mediated coronary vasoconstriction is augmented in alloxan-induced diabetic dogs during physiological increases in MV̇O2.

KW - Coronary blood flow

KW - Myocardial oxygen consumption

UR - http://www.scopus.com/inward/record.url?scp=3042608464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042608464&partnerID=8YFLogxK

U2 - 10.1152/japplphysiol.01122.2003

DO - 10.1152/japplphysiol.01122.2003

M3 - Article

C2 - 14978008

AN - SCOPUS:3042608464

VL - 97

SP - 431

EP - 438

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 1

ER -